Skip to main content
TSE:ONC

Oncolytics Biotech News Headlines

C$3.27
+0.08 (+2.51 %)
(As of 05/14/2021 11:24 AM ET)
Add
Compare
Today's Range
C$3.16
C$3.31
50-Day Range
C$3.21
C$5.80
52-Week Range
C$2.00
C$6.06
Volume58,909 shs
Average Volume268,801 shs
Market CapitalizationC$178.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Oncolytics Biotech (TSE ONC) News Headlines Today

SourceHeadline
Oncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare ConferenceOncolytics Biotech® to Participate in Virtual Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 13 at 8:00 AM
Oncolytics Biotech® Announces Annual General MeetingOncolytics Biotech® Announces Annual General Meeting
finance.yahoo.com - April 30 at 7:58 AM
Oncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual MeetingOncolytics Biotech® Announces Upcoming Presentation at the American Society of Clinical Oncology Annual Meeting
finance.yahoo.com - April 29 at 8:24 AM
Heres Why Were Not Too Worried About Oncolytics Biotechs (TSE:ONC) Cash Burn SituationHere's Why We're Not Too Worried About Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
finance.yahoo.com - April 14 at 12:00 PM
Oncolytics Biotechs Pelareorep Associated With Therapeutic Efficacy, Improved Clinical Outcomes In Breast CancerOncolytics Biotech's Pelareorep Associated With Therapeutic Efficacy, Improved Clinical Outcomes In Breast Cancer
finance.yahoo.com - April 12 at 1:58 PM
BRIEF-Oncolytics Biotech® Presents Preclinical Data On Pelareorep-Based Combination Therapies At AACR Annual MeetingBRIEF-Oncolytics Biotech® Presents Preclinical Data On Pelareorep-Based Combination Therapies At AACR Annual Meeting
msn.com - April 12 at 8:58 AM
Oncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual MeetingOncolytics Biotech® Presents Preclinical Data on Pelareorep-based Combination Therapies at the AACR Annual Meeting
finance.yahoo.com - April 12 at 8:58 AM
Oncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 StudyOncolytics Biotech® and SOLTI Achieve Primary Endpoint in AWARE-1 Study
finance.yahoo.com - April 12 at 8:58 AM
Oncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid TumorsOncolytics Biotech® to Host Key Opinion Leader Webinar to Discuss AWARE-1 Data, the Immunotherapeutic Effects of Pelareorep in Breast Cancer, and its Synergistic Activity with CAR T Cells in Solid Tumors
finance.yahoo.com - April 5 at 8:04 AM
Oncolytics Biotech (ONCY) Enters Overbought TerritoryOncolytics Biotech (ONCY) Enters Overbought Territory
finance.yahoo.com - March 25 at 1:30 PM
Oncolytics Biotech® Announces Upcoming Presentations at the AACR Annual MeetingOncolytics Biotech® Announces Upcoming Presentations at the AACR Annual Meeting
finance.yahoo.com - March 10 at 6:14 PM
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational HighlightsOncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
finance.yahoo.com - March 5 at 10:13 AM
5 Penny Stocks To Watch This Week If Biotech Is Your Focus In February5 Penny Stocks To Watch This Week If Biotech Is Your Focus In February
marketwatch.com - February 24 at 10:57 PM
Benzingas Top Ratings Upgrades, Downgrades For February 17, 2021Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2021
finance.yahoo.com - February 17 at 2:31 PM
Oncolytic Virus Immunotherapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027Oncolytic Virus Immunotherapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027
marketwatch.com - February 12 at 1:42 PM
Pancreatic Cancer Market Overview, Sales Revenue, Opportunities, Size, Share, Competitive Landscape and Comprehensive Research Study 2024Pancreatic Cancer Market Overview, Sales Revenue, Opportunities, Size, Share, Competitive Landscape and Comprehensive Research Study 2024
marketwatch.com - January 17 at 8:59 AM
Nymi survey reveals the majority of Americans would welcome using a wearable at work, as companies seek technology to plan for safe returns to workplacesNymi survey reveals the majority of Americans would welcome using a wearable at work, as companies seek technology to plan for safe returns to workplaces
finance.yahoo.com - January 13 at 8:55 AM
Top Penny Stocks To Buy According To Analysts With 42%-291% TargetsTop Penny Stocks To Buy According To Analysts With 42%-291% Targets
marketwatch.com - January 8 at 3:49 PM
Oncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer SymposiumOncolytics and SOLTI Report Clinical Synergy of Pelareorep with Checkpoint Inhibitors at the 2020 San Antonio Breast Cancer Symposium
finance.yahoo.com - December 9 at 4:50 PM
Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?Thinking about buying stock in Pfizer, Nio, Lexicon Pharmaceuticals, Oncolytics Biotech, or Boeing?
marketwatch.com - December 8 at 12:57 PM
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizers COVID Vaccine, Hematology Conference Presentations Pick Up PaceWeek Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
benzinga.com - December 6 at 9:27 AM
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?
finance.yahoo.com - November 26 at 7:14 PM
Oncolytics Biotech® Announces Abstract Publication and Upcoming Oral Presentation at the 2020 Society of Neuro-Oncology Annual MeetingOncolytics Biotech® Announces Abstract Publication and Upcoming Oral Presentation at the 2020 Society of Neuro-Oncology Annual Meeting
finance.yahoo.com - November 9 at 8:01 AM
Oncolytics Bio teams up with Roche in gastrointestinal cancer trialOncolytics Bio teams up with Roche in gastrointestinal cancer trial
seekingalpha.com - October 27 at 12:49 PM
Kymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of DirectorsKymera Therapeutics Appoints Biopharma Veterans Pamela Esposito and Jeff Albers to its Board of Directors
finance.yahoo.com - September 9 at 10:44 AM
Positive Initial Data From a Phase 1 Trial With Transgene’s Oncolytic Virus TG6002Positive Initial Data From a Phase 1 Trial With Transgene’s Oncolytic Virus TG6002
markets.businessinsider.com - September 9 at 4:33 AM
Global Oncolytic Virus Market 2020 Upcoming Trends, Latest Innovation, Advance Technology and Top Companies to 2025Global Oncolytic Virus Market 2020 Upcoming Trends, Latest Innovation, Advance Technology and Top Companies to 2025
marketwatch.com - September 7 at 10:10 PM
Oncolytics Biotech® Announces Upcoming Presentations at Investor ConferencesOncolytics Biotech® Announces Upcoming Presentations at Investor Conferences
finance.yahoo.com - September 1 at 12:05 PM
Stocks in play: Oncolytics Biotech® Inc.Stocks in play: Oncolytics Biotech® Inc.
ca.finance.yahoo.com - August 26 at 1:36 PM
Dosing underway in Oncolytics Bio/Incyte IRENE study in breast cancerDosing underway in Oncolytics Bio/Incyte IRENE study in breast cancer
seekingalpha.com - August 26 at 8:36 AM
Billions Pouring Into Drugs That Could Treat Cancer Patients with High TROP2 ExpressionsBillions Pouring Into Drugs That Could Treat Cancer Patients with High TROP2 Expressions
baystreet.ca - August 25 at 7:34 AM
Oncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2020 Results - Earnings Call TranscriptOncolytics Biotech Inc. (ONCY) CEO Matt Coffey on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 5 at 12:41 AM
Oncolytics Bio inks $40M sales dealOncolytics Bio inks $40M sales deal
seekingalpha.com - June 16 at 8:27 AM
Should You Sell IMPAC Mortgage Holdings, Inc (IMH)?Should You Sell IMPAC Mortgage Holdings, Inc (IMH)?
finance.yahoo.com - June 4 at 10:35 PM
Oncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep TreatmentOncolytics Biotech® Provides Recap of Key Opinion Leader Call Highlighting the Induction of Rapid and Persistent Immune Responses With Systemic Pelareorep Treatment
finance.yahoo.com - June 4 at 7:33 AM
Oncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual MeetingOncolytics Biotech® Presents Clinical Data Supporting a Predictive Biomarker of Pelareorep Response in Breast Cancer at the ESMO Breast Cancer Virtual Meeting
finance.yahoo.com - May 26 at 8:06 AM
Oncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual MeetingOncolytics Biotech® Announces Publication of Abstracts at the 2020 American Society of Clinical Oncology Virtual Annual Meeting
finance.yahoo.com - May 14 at 7:56 AM
3 Biotech Stocks Under $3 With 200%-Plus Upside Potential3 Biotech Stocks Under $3 With 200%-Plus Upside Potential
finance.yahoo.com - May 12 at 12:33 PM
BRIEF-Oncolytics Biotech Reports Quarterly Diluted Loss Per Share Were $0.04BRIEF-Oncolytics Biotech Reports Quarterly Diluted Loss Per Share Were $0.04
www.reuters.com - May 8 at 3:54 PM
5 Biotech Companies To Follow In 20205 Biotech Companies To Follow In 2020
www.marketwatch.com - May 5 at 9:24 AM
Oncolytic Virus Therapy Market forecast with Key Companies Profile, Supply, Trends, Cost Structure, and SWOT AnalysisOncolytic Virus Therapy Market forecast with Key Companies Profile, Supply, Trends, Cost Structure, and SWOT Analysis
www.marketwatch.com - March 27 at 2:56 PM
Edited Transcript of ONC.TO earnings conference call or presentation 5-Mar-20 10:00pm GMTEdited Transcript of ONC.TO earnings conference call or presentation 5-Mar-20 10:00pm GMT
finance.yahoo.com - March 25 at 8:34 PM
IIROC Trading Halt - ONCIIROC Trading Halt - ONC
finance.yahoo.com - March 24 at 2:05 PM
IIROC Trade Resumption - ONCIIROC Trade Resumption - ONC
finance.yahoo.com - March 24 at 2:05 PM
Biotech Brief: Why Oncolytic Viruses are Becoming a Potent Weapon Against CancerBiotech Brief: Why Oncolytic Viruses are Becoming a Potent Weapon Against Cancer
www.marketwatch.com - March 24 at 9:05 AM
Oncolytics Biotech Inc. 2019 Q4 - Results - Earnings Call PresentationOncolytics Biotech Inc. 2019 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 10 at 6:24 PM
Oncolytics Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Operational HighlightsOncolytics Biotech Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
www.finanznachrichten.de - March 7 at 7:25 AM
BRIEF-Oncolytics Biotech Reports Net Loss For Q4 Was $19.4 MlnBRIEF-Oncolytics Biotech Reports Net Loss For Q4 Was $19.4 Mln
www.reuters.com - March 5 at 7:18 PM
Oncolytics (ONCY) to Report Q4 Earnings: Whats in Store?Oncolytics (ONCY) to Report Q4 Earnings: What's in Store?
finance.yahoo.com - February 28 at 12:08 PM
Oncolytics (ONCY) to Report Q4 Earnings: What's in Store?Oncolytics (ONCY) to Report Q4 Earnings: What's in Store?
finance.yahoo.com - February 28 at 12:08 PM
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.